Literature DB >> 12395205

Changes in morphology and inward rectifier currents in human atrial myocytes depend on culture conditions.

Herbert M Himmel1, Martina Pietsch, Uwe Streller, Eva M Graf, Ursula Ravens.   

Abstract

Human atrial myocytes were cultured under systematically varied conditions in order to obtain stable cells for future gene manipulation. Transient (I(to)) and sustained outward current (I(so)), and voltage- and muscarinic receptor-activated inward rectifier K(+) currents (I(K1), I(K,ACh)) were measured in freshly isolated cells and after 5 days in culture. Myocytes were grown on polylysin or laminin in medium with or without 10 % serum (medium+S, medium-S). Cultured myocytes dedifferentiated to a greater extent in medium+S than medium-S, but independent of the chemical nature of the adherence surface. Apparent surface area increased in medium+S, whereas membrane capacitance declined under all culture conditions. I(to) of myocytes cultured in medium-S was increased. Myocytes grown on polylysin and laminin exhibited reduced I(K1) current density. Under all culture conditions, I(K,ACh) was attenuated with carbachol but hardly affected with sphingosine-1-phosphate as agonists. In conclusion, morphological and electrophysiological changes depended on serum in the culture medium rather than on adherence surface being coated with laminin or polylysin.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12395205     DOI: 10.1007/s00395-002-0375-6

Source DB:  PubMed          Journal:  Basic Res Cardiol        ISSN: 0300-8428            Impact factor:   17.165


  1 in total

1.  Consecutive-Day Ventricular and Atrial Cardiomyocyte Isolations from the Same Heart: Shifting the Cost-Benefit Balance of Cardiac Primary Cell Research.

Authors:  Joachim Greiner; Teresa Schiatti; Wenzel Kaltenbacher; Marica Dente; Alina Semenjakin; Thomas Kok; Dominik J Fiegle; Thomas Seidel; Ursula Ravens; Peter Kohl; Rémi Peyronnet; Eva A Rog-Zielinska
Journal:  Cells       Date:  2022-01-11       Impact factor: 6.600

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.